Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1992-06-11
1994-05-10
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514557, 514561, A61K 3119, A61K 31195
Patent
active
053107683
ABSTRACT:
A method of treatment of postoperative and posttraumatic patients for improving the glutamine content in skeletal muscle by administrating alpha-ketoglutarate; also, a composition for carrying out the method.
REFERENCES:
patent: 3542929 (1970-11-01), Roberts
patent: 4663166 (1987-05-01), Veech
patent: 4929449 (1990-05-01), Veech
patent: 5100677 (1992-03-01), Veech
Hammerqvist, F., et al., "Alpha-ketoglutarate preserves protein synthesis and free glutamine in skeletal muscle after surgery", Surgery (1991), vol. 109, pp. 28-36.
Wernerman, J., et al., "Alpha-ketoglutarate and postoperative muscle catabolism", The Lancet (1990), vol. 335, pp. 701-703.
Dialog 05710808, Medline 86011808, "Changes in protein metabolism in cachexia and catabolism" (1985).
The Merk Index, 10th Edition (1983), p. 762, cite #5140.
AB Erik Vinnars
Henley III Raymond J.
Waddell Frederick E.
LandOfFree
Method for improving the glutamine content in skeletal muscle an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for improving the glutamine content in skeletal muscle an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for improving the glutamine content in skeletal muscle an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2412520